Antimicrobial Agents and Chemotherapy · 2000 · 56 citations · 11 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceChemotherapyMedical MicrobiologyAntibacterial PharmacologyAntibacterial TherapyAntibiotic ResistanceDrug Resistance TestingFirst-line Antituberculosis TherapyMycobacterium Tuberculosis InfectionPhenotypic Drug Susceptibility TestingResistance In Clinical IsolatesTuberculosis Drug Resistance
Two hundred fifty isolates of Mycobacterium tuberculosis were evaluated for susceptibility to ciprofloxacin, ofloxacin, levofloxacin, grepafloxacin, trovafloxacin, and gemifloxacin (SB-265805). Levofloxacin, ciprofloxacin, and grepafloxacin showed the greatest activity (MIC for 90% of strains tested [MIC(90)] 1 microg/ml), although ofloxacin also showed good activity, with an MIC(90) of 2 microg/ml. Trovafloxacin and gemifloxacin showed lower in vitro activity, with MIC(90)s of 64 and 8 microg/ml, respectively.
11
Tuberculosis: a global overview of the situation today.
P Sudre, G.T.M. ten Dam, A. Kochi · PubMed · 1992 · 540 citations
Public Health, Infectious Disease Control, Infectious Diseases +15
Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.
M Tsukamura, Eiichi Nakamura, S Yoshii et al. · PubMed · 1985 · 157 citations
Chen Xu, Barry N. Kreiswirth, Srinand Sreevatsan et al. · The Journal of Infectious Diseases · 1996 · 110 citations